CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | Elston George Chief Financial Officer | Option exercise | +15,285 | 96,339 | ||
| 2026-01-06 | Elston George Chief Financial Officer | Shares withheld for taxes | −4,487 | $16.86 | $76K | 91,852 |
| 2026-01-06 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −15,285 | 0 | ||
| 2026-01-05 | Ribeiro Ramiro Chief Medical Officer | Option exercise 10b5-1 | +29,250 | $8.26 | $242K | 42,544 |
| 2026-01-05 | Ribeiro Ramiro Chief Medical Officer | Sale 10b5-1 | −42,544 | $17.10 | $727K | 0 |
| 2026-01-05 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −29,250 | 87,750 | ||
| 2026-01-05 | Duker Jay S. President and CEO | Option exercise | +30,000 | 81,518 | ||
| 2026-01-05 | Duker Jay S. President and CEO | Shares withheld for taxes | −14,505 | $17.43 | $253K | 67,013 |
| 2026-01-05 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −30,000 | 30,000 | ||
| 2026-01-05 | Lurker Nancy Director | Option exercise | +12,666 | 219,213 | ||
| 2026-01-05 | Lurker Nancy Director | Option exercise · Restricted Stock Units | −12,666 | 12,667 | ||
| 2026-01-05 | Elston George Chief Financial Officer | Option exercise | +15,000 | 85,457 | ||
| 2026-01-05 | Elston George Chief Financial Officer | Shares withheld for taxes | −4,403 | $17.43 | $77K | 81,054 |
| 2026-01-05 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −15,000 | 15,000 | ||
| 2026-01-03 | Ribeiro Ramiro Chief Medical Officer | Option exercise | +19,667 | 19,667 | ||
| 2026-01-03 | Ribeiro Ramiro Chief Medical Officer | Shares withheld for taxes | −6,373 | $17.48 | $111K | 13,294 |
| 2026-01-03 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Restricted Stock Units | −19,667 | 39,333 | ||
| 2026-01-03 | Duker Jay S. President and CEO | Option exercise | +65,000 | 74,965 | ||
| 2026-01-03 | Duker Jay S. President and CEO | Shares withheld for taxes | −23,447 | $17.48 | $410K | 51,518 |
| 2026-01-03 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −65,000 | 130,000 |
Page 3 of 18 · 352 trades